Global Pharmatech Announces a Patent Granted on Its Jutai Soft Capsule Product

Global Pharmatech Announces a Patent Granted on Its Jutai Soft Capsule Product Company announces it has been granted an invention patent (ZL03119221.1) on its Jutai soft capsules product containing American Ginseng and Echinacea, with patent protection over the methods of product preparation, utility as well as methods of quality control.
Home Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P. Natrol Appoints Vincent Andrich VP Sales for Prolab Division Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results Body Shop Reports 24.8 Mil Euro Sales Revenues Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label Supplement Group Targets Consumer Education Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO drugstore.com Expects to Reach Profitability Target in 2003 Human Genome Project Leads to Innovative Healthcare NPIcenter’s Career Center targets nutraceutical Industry Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Editorial: An Exercise in Synergy NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway Natural Health Trends Corp. Launches Lexxus Taiwan FDA Presents Compliance Guide for Structure/Function Claims New TrimFit® Bars Redefine Energy Bar Category New TrimFit® Bars Redefine Energy Bar Category Probiata® Offers Safe, Natural and Effective Alternative Alive & Well with Michelle Harris Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com Consumers Search for Healthy Cleaning Products That Work Nordic Naturals: Omega 3 Fatty Acids Cyanotech Names Bob Capelli as Director of Sales Omega-3 Partnership Between Fjordlaks and Borregaard Fjordlaks and Borregaard have entered into a long-term strategic agreement for Omega-3 oils, under which Fjordlaks will deliver high quality crude fish oils which will be refined and marketed by Borregaard’s wholly owned subsidiary, Denomega Nutritional Oils. Omega-3 Partnership Between Fjordlaks and Borregaard Fjordlaks and Borregaard have entered into a long-term strategic agreement for Omega-3 oils, under which Fjordlaks will deliver high quality crude fish oils which will be refined and marketed by Borregaard’s wholly owned subsidiary, Denomega Nutritional Oils. Fytokem Announces First Quarter Financial Results Company reports net income of about $26,000 on near record quarterly sales of $282,000. Fytokem Announces First Quarter Financial Results Company reports net income of about $26,000 on near record quarterly sales of $282,000. Campina Acquires Dairy Ingredient Specialist Inovatech Argentina S.A. Company has acquired Argentinean dairy ingredient specialist Inovatech Argentina S.A. which will be integrated into DMV International, a division of Campina's Industrial Products group. Campina Acquires Dairy Ingredient Specialist Inovatech Argentina S.A. Company has acquired Argentinean dairy ingredient specialist Inovatech Argentina S.A. which will be integrated into DMV International, a division of Campina's Industrial Products group. Sunset Brands Enters into Letter of Intent to Acquire ZOIC Nutrition Drink Company has entered into a letter of intent to acquire ZOIC(R) Nutrition Drink and the license for a hybrid energy drink from LifeForce Labs, LLC. Sunset Brands Enters into Letter of Intent to Acquire ZOIC Nutrition Drink Company has entered into a letter of intent to acquire ZOIC(R) Nutrition Drink and the license for a hybrid energy drink from LifeForce Labs, LLC. Sunset Brands Enters into Letter of Intent to Acquire ZOIC Nutrition Drink Company has entered into a letter of intent to acquire ZOIC(R) Nutrition Drink and the license for a hybrid energy drink from LifeForce Labs, LLC. Sunset Brands Enters into Letter of Intent to Acquire ZOIC Nutrition Drink Company has entered into a letter of intent to acquire ZOIC(R) Nutrition Drink and the license for a hybrid energy drink from LifeForce Labs, LLC. Planet Organic Health Corp Closes Acquisition of Seven-Store Ontario Chain Company announces that it has closed the acquisition of Healthy's Nutrition Centres, a seven-store health- food chain in the greater Toronto area. Planet Organic Health Corp Closes Acquisition of Seven-Store Ontario Chain Company announces that it has closed the acquisition of Healthy's Nutrition Centres, a seven-store health- food chain in the greater Toronto area. Patent Issued for SLIMALUMA Company has been awarded US Patent No. 7,060,308 for "Caralluma Extract Products and Processes for Making the same." Patent Issued for SLIMALUMA Company has been awarded US Patent No. 7,060,308 for "Caralluma Extract Products and Processes for Making the same." Patent Issued for SLIMALUMA Company has been awarded US Patent No. 7,060,308 for "Caralluma Extract Products and Processes for Making the same." Patent Issued for SLIMALUMA Company has been awarded US Patent No. 7,060,308 for "Caralluma Extract Products and Processes for Making the same." Metagenics Expands Direct International Presence with Acquisition of Belgian Nutraceutical Manufacturer and Distributor Company announces that it has concluded the acquisition of Biodynamics NV, a leading manufacturer and distributor of nutraceuticals to healthcare professionals, pharmacies, health food stores, and veterinarians in the Benelux countries--Belgium, The Netherlands, and Luxembourg. Metagenics Expands Direct International Presence with Acquisition of Belgian Nutraceutical Manufacturer and Distributor Company announces that it has concluded the acquisition of Biodynamics NV, a leading manufacturer and distributor of nutraceuticals to healthcare professionals, pharmacies, health food stores, and veterinarians in the Benelux countries--Belgium, The Netherlands, and Luxembourg. Metagenics Expands Direct International Presence with Acquisition of Belgian Nutraceutical Manufacturer and Distributor Company announces that it has concluded the acquisition of Biodynamics NV, a leading manufacturer and distributor of nutraceuticals to healthcare professionals, pharmacies, health food stores, and veterinarians in the Benelux countries--Belgium, The Netherlands, and Luxembourg. Metagenics Expands Direct International Presence with Acquisition of Belgian Nutraceutical Manufacturer and Distributor Company announces that it has concluded the acquisition of Biodynamics NV, a leading manufacturer and distributor of nutraceuticals to healthcare professionals, pharmacies, health food stores, and veterinarians in the Benelux countries--Belgium, The Netherlands, and Luxembourg. Metagenics Expands Direct International Presence with Acquisition of Belgian Nutraceutical Manufacturer and Distributor Company announces that it has concluded the acquisition of Biodynamics NV, a leading manufacturer and distributor of nutraceuticals to healthcare professionals, pharmacies, health food stores, and veterinarians in the Benelux countries--Belgium, The Netherlands, and Luxembourg. Metagenics Expands Direct International Presence with Acquisition of Belgian Nutraceutical Manufacturer and Distributor Company announces that it has concluded the acquisition of Biodynamics NV, a leading manufacturer and distributor of nutraceuticals to healthcare professionals, pharmacies, health food stores, and veterinarians in the Benelux countries--Belgium, The Netherlands, and Luxembourg. US General Import Statistics Indicate CoQ10 Supply Shortage Has Ended Recently released import statistics from USA Trade Online provides the clearest indication the enduring CoQ10 supply shortage has now been eradicated. Commodity pricing over the past few months has provided an early indication of a significant shift in supply positions from all suppliers. US General Import Statistics Indicate CoQ10 Supply Shortage Has Ended Recently released import statistics from USA Trade Online provides the clearest indication the enduring CoQ10 supply shortage has now been eradicated. Commodity pricing over the past few months has provided an early indication of a significant shift in supply positions from all suppliers. US General Import Statistics Indicate CoQ10 Supply Shortage Has Ended Recently released import statistics from USA Trade Online provides the clearest indication the enduring CoQ10 supply shortage has now been eradicated. Commodity pricing over the past few months has provided an early indication of a significant shift in supply positions from all suppliers. US General Import Statistics Indicate CoQ10 Supply Shortage Has Ended Recently released import statistics from USA Trade Online provides the clearest indication the enduring CoQ10 supply shortage has now been eradicated. Commodity pricing over the past few months has provided an early indication of a significant shift in supply positions from all suppliers. US General Import Statistics Indicate CoQ10 Supply Shortage Has Ended Recently released import statistics from USA Trade Online provides the clearest indication the enduring CoQ10 supply shortage has now been eradicated. Commodity pricing over the past few months has provided an early indication of a significant shift in supply positions from all suppliers. Martek Announces Second Quarter Financial Results Company reports revenues of $70.2 million compared to 55.8 million for the second quarter of fiscal 05, with net income of $6.3 million, or $0.19 per diluted share, compared to net income of $3.4 million, or $0.11 per diluted share, for the 2nd Qtr 05. Martek Announces Second Quarter Financial Results Company reports revenues of $70.2 million compared to 55.8 million for the second quarter of fiscal 05, with net income of $6.3 million, or $0.19 per diluted share, compared to net income of $3.4 million, or $0.11 per diluted share, for the 2nd Qtr 05. Zila Releases Its Fiscal 2006 Third Quarter Financial Results Company reports net revenues of $6.8 million, a decrease of 44%, compared to net revenues of $12.0 million for the same quarter prior year, as Zila Nutraceuticals revenues decreased to $3.6 million compared to $10.4 million for the three months ended April 30, 2005. Zila Releases Its Fiscal 2006 Third Quarter Financial Results Company reports net revenues of $6.8 million, a decrease of 44%, compared to net revenues of $12.0 million for the same quarter prior year, as Zila Nutraceuticals revenues decreased to $3.6 million compared to $10.4 million for the three months ended April 30, 2005. New Zealand Venture Firm on the Lookout for Promising Functional Food Companies Company is keen to meet with entrepreneurs who are interested to hear more about the benefits of relocating part or all of their operations to New Zealand. New Zealand Venture Firm on the Lookout for Promising Functional Food Companies Company is keen to meet with entrepreneurs who are interested to hear more about the benefits of relocating part or all of their operations to New Zealand. New Zealand Venture Firm on the Lookout for Promising Functional Food Companies Company is keen to meet with entrepreneurs who are interested to hear more about the benefits of relocating part or all of their operations to New Zealand. New Zealand Venture Firm on the Lookout for Promising Functional Food Companies Company is keen to meet with entrepreneurs who are interested to hear more about the benefits of relocating part or all of their operations to New Zealand. P.L. Thomas and Polifenoles Naturales, S.A. Announce Strategic Alliance Polifenoles Naturales, S.L. (POLINAT) European Research of Natural Products Center and producer of standardized fruit and botanical extracts and P. L. Thomas (PLT) have announced a strategic alliance to develop and market unique ingredients for the nutraceuticals, food and beverage markets. P.L. Thomas and Polifenoles Naturales, S.A. Announce Strategic Alliance Polifenoles Naturales, S.L. (POLINAT) European Research of Natural Products Center and producer of standardized fruit and botanical extracts and P. L. Thomas (PLT) have announced a strategic alliance to develop and market unique ingredients for the nutraceuticals, food and beverage markets. P.L. Thomas and Polifenoles Naturales, S.A. Announce Strategic Alliance Polifenoles Naturales, S.L. (POLINAT) European Research of Natural Products Center and producer of standardized fruit and botanical extracts and P. L. Thomas (PLT) have announced a strategic alliance to develop and market unique ingredients for the nutraceuticals, food and beverage markets. P.L. Thomas and Polifenoles Naturales, S.A. Announce Strategic Alliance Polifenoles Naturales, S.L. (POLINAT) European Research of Natural Products Center and producer of standardized fruit and botanical extracts and P. L. Thomas (PLT) have announced a strategic alliance to develop and market unique ingredients for the nutraceuticals, food and beverage markets. P.L. Thomas and Polifenoles Naturales, S.A. Announce Strategic Alliance Polifenoles Naturales, S.L. (POLINAT) European Research of Natural Products Center and producer of standardized fruit and botanical extracts and P. L. Thomas (PLT) have announced a strategic alliance to develop and market unique ingredients for the nutraceuticals, food and beverage markets. P.L. Thomas and Polifenoles Naturales, S.A. Announce Strategic Alliance Polifenoles Naturales, S.L. (POLINAT) European Research of Natural Products Center and producer of standardized fruit and botanical extracts and P. L. Thomas (PLT) have announced a strategic alliance to develop and market unique ingredients for the nutraceuticals, food and beverage markets. LycoRed Expands Natural Carotenoid Business Company announces the acquisition of the assets and business of H. Reisman Corporation, previously a subsidiary of Pharmachem Laboratories Ltd. LycoRed Expands Natural Carotenoid Business Company announces the acquisition of the assets and business of H. Reisman Corporation, previously a subsidiary of Pharmachem Laboratories Ltd. The Hain Celestial Group Acquires the Assets of the Linda McCartney(R) Brand Products and Meat-Free Business Company announces the acquisition of the Linda McCartney(R) brand (under license) frozen meat-free business from the H. J. Heinz Company, including the manufacturing facility based in Fakenham, England. The Hain Celestial Group Acquires the Assets of the Linda McCartney(R) Brand Products and Meat-Free Business Company announces the acquisition of the Linda McCartney(R) brand (under license) frozen meat-free business from the H. J. Heinz Company, including the manufacturing facility based in Fakenham, England. NutraCea Continues to Expand Its International Patent Portfolio Company announces today that its Mexican Patent Application entitled "Supportive Therapy for Diabetes, Hyperglycemia and Hypoglycemia" has been allowed by the Mexican Industrial Property Office with patent number 232655. NutraCea Continues to Expand Its International Patent Portfolio Company announces today that its Mexican Patent Application entitled "Supportive Therapy for Diabetes, Hyperglycemia and Hypoglycemia" has been allowed by the Mexican Industrial Property Office with patent number 232655. NutraCea Continues to Expand Its International Patent Portfolio Company announces today that its Mexican Patent Application entitled "Supportive Therapy for Diabetes, Hyperglycemia and Hypoglycemia" has been allowed by the Mexican Industrial Property Office with patent number 232655. Advitech Announces Signing A Definitive Agreement on the Distirbution Of Dermylex In France and Interim Financing Company announces that it has signed a definitive agreement with Cothera SAS for the French market, and has disclosed new financing. Advitech Announces Signing A Definitive Agreement on the Distirbution Of Dermylex In France and Interim Financing Company announces that it has signed a definitive agreement with Cothera SAS for the French market, and has disclosed new financing. Advitech Announces Signing A Definitive Agreement on the Distirbution Of Dermylex In France and Interim Financing Company announces that it has signed a definitive agreement with Cothera SAS for the French market, and has disclosed new financing. Advitech Announces Signing A Definitive Agreement on the Distirbution Of Dermylex In France and Interim Financing Company announces that it has signed a definitive agreement with Cothera SAS for the French market, and has disclosed new financing. Advitech Announces Signing A Definitive Agreement on the Distirbution Of Dermylex In France and Interim Financing Company announces that it has signed a definitive agreement with Cothera SAS for the French market, and has disclosed new financing. Leiner Health Products Reports Fourth Quarter and Full Year 2006 Results Company reports net sales of $173.8 million compared to $174.6 million for the same period in fiscal 2005, including growth in US sales and a decline of $5.4 million in Canaidan sales. The US sales increase stems from the continued growth of joint care products and sales from the PFI acquisition. Company reports net income of $ .4 million for the quarter, compared to net income of $6.4 million for the same period in fiscal 2005. Leiner Health Products Reports Fourth Quarter and Full Year 2006 Results Company reports net sales of $173.8 million compared to $174.6 million for the same period in fiscal 2005, including growth in US sales and a decline of $5.4 million in Canaidan sales. The US sales increase stems from the continued growth of joint care products and sales from the PFI acquisition. Company reports net income of $ .4 million for the quarter, compared to net income of $6.4 million for the same period in fiscal 2005. Leiner Health Products Reports Fourth Quarter and Full Year 2006 Results Company reports net sales of $173.8 million compared to $174.6 million for the same period in fiscal 2005, including growth in US sales and a decline of $5.4 million in Canaidan sales. The US sales increase stems from the continued growth of joint care products and sales from the PFI acquisition. Company reports net income of $ .4 million for the quarter, compared to net income of $6.4 million for the same period in fiscal 2005. Lipid Nutrition and Tempo Canada Inc. Announce Strategic Partnership Lipid Nutrition and Tempo Canada Inc. announced a strategic partnership to offer Lipid Nutrition ingredients in Canada. Lipid Nutrition and Tempo Canada Inc. Announce Strategic Partnership Lipid Nutrition and Tempo Canada Inc. announced a strategic partnership to offer Lipid Nutrition ingredients in Canada. Lipid Nutrition and Tempo Canada Inc. Announce Strategic Partnership Lipid Nutrition and Tempo Canada Inc. announced a strategic partnership to offer Lipid Nutrition ingredients in Canada. Nestle buys weight-loss firm Jenny Craig Company agrees to buy weight-loss company Jenny Craig for $600 million. Nestle buys weight-loss firm Jenny Craig Company agrees to buy weight-loss company Jenny Craig for $600 million. Nestle buys weight-loss firm Jenny Craig Company agrees to buy weight-loss company Jenny Craig for $600 million. Nestle buys weight-loss firm Jenny Craig Company agrees to buy weight-loss company Jenny Craig for $600 million. Nestle buys weight-loss firm Jenny Craig Company agrees to buy weight-loss company Jenny Craig for $600 million. Austrian Court Upholds Novogen Patent for Red Clover Isoflavones Vienna Commercial Court has found that Novogen's (NVGN) isoflavone invention and patent is novel and inventive, and found APOtrend's menopause product Vitalady infringed Novogen's patent and the provisional injunction against Vitalady has been upheld. Austrian Court Upholds Novogen Patent for Red Clover Isoflavones Vienna Commercial Court has found that Novogen's (NVGN) isoflavone invention and patent is novel and inventive, and found APOtrend's menopause product Vitalady infringed Novogen's patent and the provisional injunction against Vitalady has been upheld. Austrian Court Upholds Novogen Patent for Red Clover Isoflavones Vienna Commercial Court has found that Novogen's (NVGN) isoflavone invention and patent is novel and inventive, and found APOtrend's menopause product Vitalady infringed Novogen's patent and the provisional injunction against Vitalady has been upheld. Natural Health Trends Corp. Announces First Quarter 2006 Results Company reports net sales of $39.5 million, compared to $42.8 million for the first quarter a year ago, with decrease due to sale of the Company's 51% equity interest in KGC Networks,; outside of that, increase was 15%, over the comparable period in the prior year. Company incurred a net loss of $1.1 million, or $0.15 per fully diluted share, compared to a net income of $2.8 million or $0.34 per fully diluted share a year ago in the comparable quarter. Natural Health Trends Corp. Announces First Quarter 2006 Results Company reports net sales of $39.5 million, compared to $42.8 million for the first quarter a year ago, with decrease due to sale of the Company's 51% equity interest in KGC Networks,; outside of that, increase was 15%, over the comparable period in the prior year. Company incurred a net loss of $1.1 million, or $0.15 per fully diluted share, compared to a net income of $2.8 million or $0.34 per fully diluted share a year ago in the comparable quarter. InterHealth Names Pathway Exclusive Distributor for Australia and New Zealand Company announces the appointment of Pathway International Pty Ltd as its exclusive distributor for the Australian and New Zealand markets. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Another Reason to Choose Healthy Lifestyle Habits Another Reason to Choose Healthy Lifestyle Habits	JILIN, China, June 9, 2006 /Xinhua-PRNewswire via COMTEX/ -- Global Pharmatech, Inc. (OTC Bulletin Board: GBLP.OB) a company that develops, manufactures and markets proprietary drugs and nutritional supplements that are based on modernized Chinese medicine and bio-pharmacy, today announced that it had been granted an invention patent on its Jutai soft capsules product. An invention patent is China's highest and most prestigious grade of patent protection, and is given to technology that is considered genuinely innovative. The State Intellectual Property of the People's Republic of China granted patent protection for the Jutai soft capsule as ''an immune modulating and anti-fatigue product.'' This patent also protects the methods of product preparation, utility as well as methods of quality control. The Chinese patent number is ZL03119221.1. Jutai soft capsules consist of active ingredients of American Ginseng and Echinacea, and the product was developed in accordance with the theory of Traditional Chinese Medicine. Pharmacology studies showed that Jutai enhanced immune activity and had an anti-fatigue function in animal models. Since the product's launch in China in 2003, no side effects have been reported. Dr. Xiaobo Sun, CEO of Global Pharmatech, is one of the most distinguished scientists in the field of botanical medicines. He stated, ''We are extremely pleased to have been awarded a patent on this product. People are overworked and multi-tasking these days, and they are looking for ways to boost their energy. We developed Jutai soft capsule as a dietary supplement to meet precisely this major need in the market. And with the protection of this patent for the next 20 years, we are in a better position to ramp up future sales.'' About Global Pharmatech Global Pharmatech, through its subsidiaries, develops, manufactures and markets proprietary drugs that are based on Traditional Chinese Medicine using modern facilities and advanced R&D technologies. The company offers a full range of start-to-finish biotech services, from research and testing to manufacture and sale of liquid and solid dose products. The Company employs unique proprietary extraction methods and also licenses patents and technologies for botanical/biological drug products. Global Pharamtech's operations are currently based in the People's Republic of China with sales distribution centers in China, Malaysia, Singapore and Indonesia. For more information, please visit Global Pharmatech.com Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995 This news release contains forward-looking statements within the meaning of the ''safe harbour'' provisions of the Private Securities Litigation Reform Act of 1995. These statements are based upon our current expectations and speak only as of the date hereof. Our actual results may differ materially and adversely from those expressed in any forward-looking statements as a result of various factors and uncertainties, including our ability to successfully develop and commercialize products, competitive products in our key markets, changes in consumer demand for our products, legislative, regulatory and competitive developments and general economic conditions. Our SEC filings discuss some of the important risk factors that may affect our business, results of operations and financial condition. We undertake no obligation to revise or update publicly any forward-looking statements for any reason.
Powered By Traffic Booster Absolute News Manager Plug-in by Xigla Software